All In Biotech

Drug Trial Radar · NCT03460652

KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD

A Multicenter, Dose-Optimized, Open-Label Safety Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder

Last checked: Nov 19, 2026Latest source record: Jul 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

282

Actual

Start

Mar 13, 2018

Primary completion

Jun 20, 2019

Study completion Jul 9, 2019

Sponsor

Lead sponsor
Zevra TherapeuticsIndustry
Sponsor type
Industry
First posted
Mar 9, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multicenter, dose-optimized, open-label safety study with KP415 in children with Attention-Deficit/Hyperactivity Disorder (ADHD).

Conditions

  • ADHD

Interventions

  • KP415 oral capsuleDrug

    Once-daily oral dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subjects With Treatment-Emergent Adverse Events (TEAEs)Time frame: Up to 12 months

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • Woodland International Research

    Little Rock, Arkansas

  • MCB Clinical Research Centers

    Colorado Springs, Colorado

  • Meridien Research

    Bradenton, Florida

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida

  • Innovative Clinical Research, Inc.

    Lauderhill, Florida

  • Meridien Research

    Maitland, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Capstone Clinical Research

    Libertyville, Illinois

  • Psychiatric Associates

    Overland Park, Kansas

  • Center for Psychiatry and Behavioral Medicine, Inc.

    Las Vegas, Nevada

  • Hassman Research Institute

    Berlin, New Jersey

  • Neuro-Behavioral Clinical Research

    Canton, Ohio

  • Midwest Clinical Research Center, LLC

    Dayton, Ohio

  • Oregon Center for Clinical Investigations, Inc.

    Portland, Oregon

  • Oregon Center for Clinical Investigations, Inc.

    Salem, Oregon

  • Clinical Neuroscience Solutions, Inc.

    Memphis, Tennessee

  • FutureSearch Trials

    Austin, Texas

  • Bayou City Research, Ltd.

    Houston, Texas

  • Houston Clinical Trials

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.